Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1 MAD Study of Zaloglanstat in Healthy and Elderly Subjects
NCT02361034Phase 1Completed
- Start
- Jan 2015
- Primary completion
- Sep 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial in osteoarthritis (OA), rheumatoid arthritis (RA) and pain comparing GRC 27864 with Placebo (2 arms). Primary endpoint: Number of Treatment-Emergent Adverse Events and Serious Adverse Events. Started Jan 2015; status: completed.
02
Drugs
zaloglanstat
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)pain
Beyond the preview
Go deeper on NCT02361034.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02361034.